Sleep is a fundamental human right crucial for overall health and well-being, yet it remains elusive for many.However, experts point out that Korean adolescents, truck drivers, shift workers, and women who are raising children do not get enough sleep and need policy support not only from individuals
Seoul National University Bundang Hospital (SNUBH) said it would receive the Presidential Commendation for Global Healthcare Achievement in the 14th Global Healthcare & Medical Tourism held at COEX, southern Seoul, from Thursday.The hospital said the presidential citation is related to the global he
Korean trainee doctors, including interns and residents, have appealed to the International Labor Organization (ILO) for assistance in addressing the Seoul government's directive to resume operations.In a news release distributed on Wednesday, the Korean Intern Resident Association (KIRA) said it ha
The International Vaccine Institute (IVI) said on Thursday that it has named three vaccine developers as co-recipients of the 2024 IVI-SK bioscience Park MahnHoon Award for developing an oral cholera vaccine, and Covid-19 and respiratory syncytial virus (RSV) vaccines, respectively. Jan Holmgren, a
A collaborative research team from Severance Hospital and the Korea Advanced Institute of Science and Technology (KAIST) has uncovered mechanisms that contribute to the early development of resistance to chemotherapy in pancreatic cancer treatment.Despite advances in the survival rates of other intr
Obesity is becoming a serious problem in Korea.A recent statistical report published by the Ministry of Health and Welfare and the Korea Health Promotion Institute on Monday highlighted a worrying obesity trend in the aftermath of the Covid-19 pandemic, showing a sharp rise in obesity rates across a
The government has begun a full-scale financial injection to fill the vacancies left by interns and residents who resigned en masse to protest against the government’s increase in medical school enrollment quota.Starting in March, for instance, the government will pay a monthly subsidy of 18 million
NGeneBio, a company specializing in next-generation sequencing-based precision diagnostic platforms, said Wednesday that it has signed a business agreement with Genolution, a molecular diagnostics company."We signed this business agreement to provide NGS (next-generation sequencing) testing services
Korean medical professors who have announced their resignations, urging dialogue with the government, have issued a stark warning of an impending healthcare crisis in the country. They highlight that hospitals, which have been reducing their services for nearly a month following the departure of tra
Philips Korea said Wednesday that it would showcase the company’s broad ultrasound portfolio for clinical settings at the 39th Korea International Medical & Hospital Equipment Show (KIMES 2024) at COEX, southern Seoul, from Thursday to Sunday.The medical field strives to realize precision medicine b
Lunit said it has received the first-phase approval from the New Zealand High Court for its acquisition of Volpara Health Technologies.Volpara, established in 2009 in Wellington, New Zealand, specializes in AI-based breast cancer screening solutions. It has supplied its technology to over 2,000 medi
A joint research team of Seoul National University Bundang Hospital (SNUBH) and Sung Kyun Kwan University (SKKU)-Samsung Medical Center (SMC) has released the results of a genetic study on the relationship between creativity and mental disorders.Professor Myung Woo-jae at the Department of Neuropsyc
The Medical Device Industry Promotion Foundation (MEDIF) will hold the “International Joint Cooperation Seminar on Medical Device Technology and Standard Trends in Orthopedics between Korea and Brazil” based on the TC-Linked Cooperation Foundation for Pre-empting International Standards in Medical D
The Korean Society for the Study of Obesity (KSSO) is now busy revising its guidelines ahead of Novo Nordisk's anticipated domestic launch of its obesity treatment Wegovy (semaglutide) late this year.According to a recent seminar of the Guidelines Committee at the KSSO’s 59th spring conference, the
Korean pharmaceutical companies are announcing their general shareholders’ meeting schedules.According to the Kosdaq Listed Companies Association, the key dates for shareholder meetings in 2024 are March 22, 27, and 29, when the domestic drugmakers hold annual shareholder meetings.In these meetings,
Liveome, an affiliate of Medytox, said it completed the phase 1 clinical trial in Australia for its gene-recombinant microbiome drug, LIV001.The drug is being developed as a treatment for inflammatory bowel disease, a chronic immune disorder that has been challenging to manage with existing therapie
HK inno.N is embroiled in a crisis rumor after it lost the first round of patent litigation for the crystalline form of its P-CAB-based gastroesophageal reflux disease (GERD) drug, K-CAB Tab (tegoprazan).However, the company denied such concerns, expressing confidence about the continued growth of K
Dx&Vx, a diagnostics and vaccine company, said Tuesday that its Chinese subsidiary, Dx&Vx BJ, has set 2024 revenue and operating profit ratio targets of 38 billion won ($29 million) and 25 percent, respectively.In its first full year of operation last year, Dx&Vx BJ achieved sales of 14.8 billion wo
Professors from Seoul National University (SNU) College of Medicine have proposed forming a consultative body to resolve the ongoing medical turmoil, which would include the government, the medical community, lawmakers, medical residents, and civic groups representing the public.They also suggested
"Korea is known for its successful clinical trials. However, underneath it is Korea’s characteristics of frequently delayed reimbursement for new drugs. I think part of it is to ensure access to new drugs by participating in clinical trials."Ingrid A. Mayer, vice president of global clinical strateg